BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 476569 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H28N6O2/c1-3-4-9-32-20-13-19(14-25-15-20)24-28-27-23-17(2)26-21-6-5-18(12-22(21)30(23)24)16-29-7-10-31-11-8-29/h5-6,12-15H,3-4,7-11,16H2,1-2H3 JJQZDOKXARNTKH-UHFFFAOYSA-N 50026821 CHEMBL3331521::US11419874, Example 10::US9669035, B-1b cGMP-dependent 3',5'-cyclic phosphodiesterase Human 13 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026821&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search Q2T 4D08 71153408 103936405 CHEMBL3331521 ZINC28227929 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476570 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H28N6O2/c1-3-4-9-32-20-13-19(14-25-15-20)24-28-27-23-17(2)26-21-6-5-18(12-22(21)30(23)24)16-29-7-10-31-11-8-29/h5-6,12-15H,3-4,7-11,16H2,1-2H3 JJQZDOKXARNTKH-UHFFFAOYSA-N 50026821 CHEMBL3331521::US11419874, Example 10::US9669035, B-1b cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 4800 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026821&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search Q2T 4D08 71153408 103936405 CHEMBL3331521 ZINC28227929 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476571 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H28N6O2/c1-3-4-9-32-20-13-19(14-25-15-20)24-28-27-23-17(2)26-21-6-5-18(12-22(21)30(23)24)16-29-7-10-31-11-8-29/h5-6,12-15H,3-4,7-11,16H2,1-2H3 JJQZDOKXARNTKH-UHFFFAOYSA-N 50026821 CHEMBL3331521::US11419874, Example 10::US9669035, B-1b cGMP-dependent 3',5'-cyclic phosphodiesterase Human 7.40 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026821&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search Q2T 4D08 71153408 103936405 CHEMBL3331521 ZINC28227929 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476572 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H28N6O2/c1-3-4-9-32-20-13-19(14-25-15-20)24-28-27-23-17(2)26-21-6-5-18(12-22(21)30(23)24)16-29-7-10-31-11-8-29/h5-6,12-15H,3-4,7-11,16H2,1-2H3 JJQZDOKXARNTKH-UHFFFAOYSA-N 50026821 CHEMBL3331521::US11419874, Example 10::US9669035, B-1b cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 4100 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026821&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search Q2T 4D08 71153408 103936405 CHEMBL3331521 ZINC28227929 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476573 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C25H28ClN5O2/c1-3-4-11-33-19-6-7-21(26)20(15-19)25-29-28-24-17(2)27-22-8-5-18(14-23(22)31(24)25)16-30-9-12-32-13-10-30/h5-8,14-15H,3-4,9-13,16H2,1-2H3 GSHAVWDELPHUJH-UHFFFAOYSA-N 50026826 CHEMBL3331517::US11419874, Example 9::US9669035, B-2 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 7.80 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026826&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153282 103936410 CHEMBL3331517 ZINC29213357 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476574 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C25H28ClN5O2/c1-3-4-11-33-19-6-7-21(26)20(15-19)25-29-28-24-17(2)27-22-8-5-18(14-23(22)31(24)25)16-30-9-12-32-13-10-30/h5-8,14-15H,3-4,9-13,16H2,1-2H3 GSHAVWDELPHUJH-UHFFFAOYSA-N 50026826 CHEMBL3331517::US11419874, Example 9::US9669035, B-2 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1600 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026826&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153282 103936410 CHEMBL3331517 ZINC29213357 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476575 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1ccccc1Cl InChI=1S/C21H20ClN5O/c1-14-20-24-25-21(16-4-2-3-5-17(16)22)27(20)19-12-15(6-7-18(19)23-14)13-26-8-10-28-11-9-26/h2-7,12H,8-11,13H2,1H3 LZRGPVBUCASWQB-UHFFFAOYSA-N 50425123 CHEMBL2313234::US9669035, B-3 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 2.30 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425123&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153436 164153998 CHEMBL2313234 ZINC95593814 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476576 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1ccccc1Cl InChI=1S/C21H20ClN5O/c1-14-20-24-25-21(16-4-2-3-5-17(16)22)27(20)19-12-15(6-7-18(19)23-14)13-26-8-10-28-11-9-26/h2-7,12H,8-11,13H2,1H3 LZRGPVBUCASWQB-UHFFFAOYSA-N 50425123 CHEMBL2313234::US9669035, B-3 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 34 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425123&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153436 164153998 CHEMBL2313234 ZINC95593814 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476577 CCNCc1ccc2nc(C)c3nnc(-c4ccccc4Cl)n3c2c1 InChI=1S/C19H18ClN5/c1-3-21-11-13-8-9-16-17(10-13)25-18(12(2)22-16)23-24-19(25)14-6-4-5-7-15(14)20/h4-10,21H,3,11H2,1-2H3 PMOYHZUHMRBKJN-UHFFFAOYSA-N 50425125 CHEMBL2313232::US9669035, B-4 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 20 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425125&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153343 164154000 CHEMBL2313232 ZINC95594034 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476578 CCNCc1ccc2nc(C)c3nnc(-c4ccccc4Cl)n3c2c1 InChI=1S/C19H18ClN5/c1-3-21-11-13-8-9-16-17(10-13)25-18(12(2)22-16)23-24-19(25)14-6-4-5-7-15(14)20/h4-10,21H,3,11H2,1-2H3 PMOYHZUHMRBKJN-UHFFFAOYSA-N 50425125 CHEMBL2313232::US9669035, B-4 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 160 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425125&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153343 164154000 CHEMBL2313232 ZINC95594034 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476579 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1c(F)cccc1Cl InChI=1S/C21H19ClFN5O/c1-13-20-25-26-21(19-15(22)3-2-4-16(19)23)28(20)18-11-14(5-6-17(18)24-13)12-27-7-9-29-10-8-27/h2-6,11H,7-10,12H2,1H3 BXKLAYQKTVKJCY-UHFFFAOYSA-N 50444038 CHEMBL3092563::US9669035, B-5 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 1.40 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50444038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50444038&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153391 194941934 CHEMBL3092563 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476580 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1c(F)cccc1Cl InChI=1S/C21H19ClFN5O/c1-13-20-25-26-21(19-15(22)3-2-4-16(19)23)28(20)18-11-14(5-6-17(18)24-13)12-27-7-9-29-10-8-27/h2-6,11H,7-10,12H2,1H3 BXKLAYQKTVKJCY-UHFFFAOYSA-N 50444038 CHEMBL3092563::US9669035, B-5 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 14 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50444038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50444038&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153391 194941934 CHEMBL3092563 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476581 CC(C)Oc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H26ClN5O2/c1-15(2)32-18-5-6-20(25)19(13-18)24-28-27-23-16(3)26-21-7-4-17(12-22(21)30(23)24)14-29-8-10-31-11-9-29/h4-7,12-13,15H,8-11,14H2,1-3H3 JBSVWNORKAJZAE-UHFFFAOYSA-N 50026827 CHEMBL3331516::US9669035, B-6 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 4.80 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026827&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153302 103936411 CHEMBL3331516 ZINC29211039 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476582 CC(C)Oc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H26ClN5O2/c1-15(2)32-18-5-6-20(25)19(13-18)24-28-27-23-16(3)26-21-7-4-17(12-22(21)30(23)24)14-29-8-10-31-11-9-29/h4-7,12-13,15H,8-11,14H2,1-3H3 JBSVWNORKAJZAE-UHFFFAOYSA-N 50026827 CHEMBL3331516::US9669035, B-6 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1900 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026827&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153302 103936411 CHEMBL3331516 ZINC29211039 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476583 CCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C23H24ClN5O2/c1-3-31-17-5-6-19(24)18(13-17)23-27-26-22-15(2)25-20-7-4-16(12-21(20)29(22)23)14-28-8-10-30-11-9-28/h4-7,12-13H,3,8-11,14H2,1-2H3 PQYOTCFMIISAPG-UHFFFAOYSA-N 50026829 CHEMBL3331514::US9669035, B-7 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 6.20 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026829&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153427 103936413 CHEMBL3331514 ZINC29213334 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476584 CCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C23H24ClN5O2/c1-3-31-17-5-6-19(24)18(13-17)23-27-26-22-15(2)25-20-7-4-16(12-21(20)29(22)23)14-28-8-10-30-11-9-28/h4-7,12-13H,3,8-11,14H2,1-2H3 PQYOTCFMIISAPG-UHFFFAOYSA-N 50026829 CHEMBL3331514::US9669035, B-7 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 260 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026829&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153427 103936413 CHEMBL3331514 ZINC29213334 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476585 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H26ClN5O2/c1-3-10-32-18-5-6-20(25)19(14-18)24-28-27-23-16(2)26-21-7-4-17(13-22(21)30(23)24)15-29-8-11-31-12-9-29/h4-7,13-14H,3,8-12,15H2,1-2H3 AFHVGEIXWXGUNT-UHFFFAOYSA-N 50026828 CHEMBL3331515::US9669035, B-8 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 6.50 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026828&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153106 103936412 CHEMBL3331515 ZINC05965202 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476586 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H26ClN5O2/c1-3-10-32-18-5-6-20(25)19(14-18)24-28-27-23-16(2)26-21-7-4-17(13-22(21)30(23)24)15-29-8-11-31-12-9-29/h4-7,13-14H,3,8-12,15H2,1-2H3 AFHVGEIXWXGUNT-UHFFFAOYSA-N 50026828 CHEMBL3331515::US9669035, B-8 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 320 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026828&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153106 103936412 CHEMBL3331515 ZINC05965202 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476587 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1cc(F)ccc1Cl InChI=1S/C21H19ClFN5O/c1-13-20-25-26-21(16-11-15(23)3-4-17(16)22)28(20)19-10-14(2-5-18(19)24-13)12-27-6-8-29-9-7-27/h2-5,10-11H,6-9,12H2,1H3 QSBNCXCDYHHCOY-UHFFFAOYSA-N 179970 US9669035, B-9 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 9.50 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179970&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 134128232 373987208 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476588 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1cc(F)ccc1Cl InChI=1S/C21H19ClFN5O/c1-13-20-25-26-21(16-11-15(23)3-4-17(16)22)28(20)19-10-14(2-5-18(19)24-13)12-27-6-8-29-9-7-27/h2-5,10-11H,6-9,12H2,1H3 QSBNCXCDYHHCOY-UHFFFAOYSA-N 179970 US9669035, B-9 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 85 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179970&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 134128232 373987208 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476589 COc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C22H22ClN5O2/c1-14-21-25-26-22(17-12-16(29-2)4-5-18(17)23)28(21)20-11-15(3-6-19(20)24-14)13-27-7-9-30-10-8-27/h3-6,11-12H,7-10,13H2,1-2H3 VDIAEIJDVYOMLE-UHFFFAOYSA-N 50026820 CHEMBL3331513::US9669035, B-10 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 10.00 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026820&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153209 103936404 CHEMBL3331513 ZINC28226870 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476590 COc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C22H22ClN5O2/c1-14-21-25-26-22(17-12-16(29-2)4-5-18(17)23)28(21)20-11-15(3-6-19(20)24-14)13-27-7-9-30-10-8-27/h3-6,11-12H,7-10,13H2,1-2H3 VDIAEIJDVYOMLE-UHFFFAOYSA-N 50026820 CHEMBL3331513::US9669035, B-10 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 100 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026820&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153209 103936404 CHEMBL3331513 ZINC28226870 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476591 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C23H26ClN5O/c1-5-6-11-30-17-8-9-19(24)18(13-17)23-27-26-22-15(2)25-20-10-7-16(14-28(3)4)12-21(20)29(22)23/h7-10,12-13H,5-6,11,14H2,1-4H3 LFPMUKYZLLOJCK-UHFFFAOYSA-N 179972 US9669035, B-11 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 11 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179972&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 90021179 373987209 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476592 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C23H26ClN5O/c1-5-6-11-30-17-8-9-19(24)18(13-17)23-27-26-22-15(2)25-20-10-7-16(14-28(3)4)12-21(20)29(22)23/h7-10,12-13H,5-6,11,14H2,1-4H3 LFPMUKYZLLOJCK-UHFFFAOYSA-N 179972 US9669035, B-11 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 2100 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179972&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 90021179 373987209 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476593 COc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C21H22N6O2/c1-14-20-24-25-21(16-10-17(28-2)12-22-11-16)27(20)19-9-15(3-4-18(19)23-14)13-26-5-7-29-8-6-26/h3-4,9-12H,5-8,13H2,1-2H3 MUTVZBOSDNBOEV-UHFFFAOYSA-N 50026825 CHEMBL3331518::US9669035, B-12 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 12 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026825&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153268 103936409 CHEMBL3331518 ZINC28229125 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476594 COc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C21H22N6O2/c1-14-20-24-25-21(16-10-17(28-2)12-22-11-16)27(20)19-9-15(3-4-18(19)23-14)13-26-5-7-29-8-6-26/h3-4,9-12H,5-8,13H2,1-2H3 MUTVZBOSDNBOEV-UHFFFAOYSA-N 50026825 CHEMBL3331518::US9669035, B-12 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 270 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026825&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153268 103936409 CHEMBL3331518 ZINC28229125 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476595 CN(C)Cc1ccc2nc(C)c3nnc(-c4ccccc4Cl)n3c2c1 InChI=1S/C19H18ClN5/c1-12-18-22-23-19(14-6-4-5-7-15(14)20)25(18)17-10-13(11-24(2)3)8-9-16(17)21-12/h4-10H,11H2,1-3H3 XEABXHPHIWCPSN-UHFFFAOYSA-N 50425124 CHEMBL2313233::US9669035, B-13 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 20 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425124&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71520601 164153999 CHEMBL2313233 ZINC95593610 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476596 CN(C)Cc1ccc2nc(C)c3nnc(-c4ccccc4Cl)n3c2c1 InChI=1S/C19H18ClN5/c1-12-18-22-23-19(14-6-4-5-7-15(14)20)25(18)17-10-13(11-24(2)3)8-9-16(17)21-12/h4-10H,11H2,1-3H3 XEABXHPHIWCPSN-UHFFFAOYSA-N 50425124 CHEMBL2313233::US9669035, B-13 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 110 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50425124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50425124&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71520601 164153999 CHEMBL2313233 ZINC95593610 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476597 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C22H24ClN5O/c1-4-10-29-16-7-8-18(23)17(12-16)22-27-26-21-14(3)25-19-9-6-15(13-24-5-2)11-20(19)28(21)22/h6-9,11-12,24H,4-5,10,13H2,1-3H3 MSHIPDFLJNFAJC-UHFFFAOYSA-N 179977 US9669035, B-14 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 21 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179977&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152293 373987212 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476598 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C22H24ClN5O/c1-4-10-29-16-7-8-18(23)17(12-16)22-27-26-21-14(3)25-19-9-6-15(13-24-5-2)11-20(19)28(21)22/h6-9,11-12,24H,4-5,10,13H2,1-3H3 MSHIPDFLJNFAJC-UHFFFAOYSA-N 179977 US9669035, B-14 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1800 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179977&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152293 373987212 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476599 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H24ClN5O/c1-5-10-29-16-7-8-18(23)17(12-16)22-26-25-21-14(2)24-19-9-6-15(13-27(3)4)11-20(19)28(21)22/h6-9,11-12H,5,10,13H2,1-4H3 BLJXRMKAAJLGJY-UHFFFAOYSA-N 179978 US9669035, B-15 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 22 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179978&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152109 373987213 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476600 CCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H24ClN5O/c1-5-10-29-16-7-8-18(23)17(12-16)22-26-25-21-14(2)24-19-9-6-15(13-27(3)4)11-20(19)28(21)22/h6-9,11-12H,5,10,13H2,1-4H3 BLJXRMKAAJLGJY-UHFFFAOYSA-N 179978 US9669035, B-15 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1500 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179978&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152109 373987213 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476601 CCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C23H26N6O2/c1-3-8-31-19-12-18(13-24-14-19)23-27-26-22-16(2)25-20-5-4-17(11-21(20)29(22)23)15-28-6-9-30-10-7-28/h4-5,11-14H,3,6-10,15H2,1-2H3 RXQBGBZOHKWYBQ-UHFFFAOYSA-N 50026824 CHEMBL3331519::US9669035, B-16 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 30 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026824&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153417 103936408 CHEMBL3331519 ZINC28225946 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476602 CCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C23H26N6O2/c1-3-8-31-19-12-18(13-24-14-19)23-27-26-22-16(2)25-20-5-4-17(11-21(20)29(22)23)15-28-6-9-30-10-7-28/h4-5,11-14H,3,6-10,15H2,1-2H3 RXQBGBZOHKWYBQ-UHFFFAOYSA-N 50026824 CHEMBL3331519::US9669035, B-16 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 6200 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50026824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50026824&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153417 103936408 CHEMBL3331519 ZINC28225946 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476603 CC(C)Oc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H24ClN5O/c1-13(2)29-16-7-8-18(23)17(11-16)22-26-25-21-14(3)24-19-9-6-15(12-27(4)5)10-20(19)28(21)22/h6-11,13H,12H2,1-5H3 VMGBREZRTHHNMB-UHFFFAOYSA-N 179980 US9669035, B-17 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 35 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179980&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152018 373987215 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476604 CC(C)Oc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H24ClN5O/c1-13(2)29-16-7-8-18(23)17(11-16)22-26-25-21-14(3)24-19-9-6-15(12-27(4)5)10-20(19)28(21)22/h6-11,13H,12H2,1-5H3 VMGBREZRTHHNMB-UHFFFAOYSA-N 179980 US9669035, B-17 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1600 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179980&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152018 373987215 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476605 CCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C21H22ClN5O/c1-5-28-15-7-8-17(22)16(11-15)21-25-24-20-13(2)23-18-9-6-14(12-26(3)4)10-19(18)27(20)21/h6-11H,5,12H2,1-4H3 NDAIEAHJBPRDFW-UHFFFAOYSA-N 179981 US9669035, B-18 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 36 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179981&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71498888 373987216 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476606 CCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C21H22ClN5O/c1-5-28-15-7-8-17(22)16(11-15)21-25-24-20-13(2)23-18-9-6-14(12-26(3)4)10-19(18)27(20)21/h6-11H,5,12H2,1-4H3 NDAIEAHJBPRDFW-UHFFFAOYSA-N 179981 US9669035, B-18 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 320 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179981&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71498888 373987216 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476607 CCNCc1ccc2nc(C)c3nnc(-c4cc(OC(C)C)ccc4Cl)n3c2c1 InChI=1S/C22H24ClN5O/c1-5-24-12-15-6-9-19-20(10-15)28-21(14(4)25-19)26-27-22(28)17-11-16(29-13(2)3)7-8-18(17)23/h6-11,13,24H,5,12H2,1-4H3 PKCYMHQCHPYQET-UHFFFAOYSA-N 179982 US9669035, B-19 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 46 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179982&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152290 373987217 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476608 CCNCc1ccc2nc(C)c3nnc(-c4cc(OC(C)C)ccc4Cl)n3c2c1 InChI=1S/C22H24ClN5O/c1-5-24-12-15-6-9-19-20(10-15)28-21(14(4)25-19)26-27-22(28)17-11-16(29-13(2)3)7-8-18(17)23/h6-11,13,24H,5,12H2,1-4H3 PKCYMHQCHPYQET-UHFFFAOYSA-N 179982 US9669035, B-19 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 8500 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179982&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152290 373987217 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476609 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNC(C)C)cc3n12 InChI=1S/C24H28ClN5O/c1-5-6-11-31-18-8-9-20(25)19(13-18)24-29-28-23-16(4)27-21-10-7-17(14-26-15(2)3)12-22(21)30(23)24/h7-10,12-13,15,26H,5-6,11,14H2,1-4H3 RIDZVINUIPDLCQ-UHFFFAOYSA-N 179983 US9669035, B-20 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 45 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179983&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153254 373987218 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476610 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNC(C)C)cc3n12 InChI=1S/C24H28ClN5O/c1-5-6-11-31-18-8-9-20(25)19(13-18)24-29-28-23-16(4)27-21-10-7-17(14-26-15(2)3)12-22(21)30(23)24/h7-10,12-13,15,26H,5-6,11,14H2,1-4H3 RIDZVINUIPDLCQ-UHFFFAOYSA-N 179983 US9669035, B-20 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 4200 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=179983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=179983&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153254 373987218 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476611 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C22H26N6O/c1-4-6-9-29-18-11-17(13-24-14-18)22-27-26-21-15(3)25-19-8-7-16(12-23-5-2)10-20(19)28(21)22/h7-8,10-11,13-14,23H,4-6,9,12H2,1-3H3 XKVJQGZBJHTMTI-UHFFFAOYSA-N 181673 US9669035, B-21 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 49 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181673&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153285 373987219 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476612 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C22H26N6O/c1-4-6-9-29-18-11-17(13-24-14-18)22-27-26-21-15(3)25-19-8-7-16(12-23-5-2)10-20(19)28(21)22/h7-8,10-11,13-14,23H,4-6,9,12H2,1-3H3 XKVJQGZBJHTMTI-UHFFFAOYSA-N 181673 US9669035, B-21 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181673&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153285 373987219 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476613 CCNCc1ccc2nc(C)c3nnc(-c4cc(OCC)ccc4Cl)n3c2c1 InChI=1S/C21H22ClN5O/c1-4-23-12-14-6-9-18-19(10-14)27-20(13(3)24-18)25-26-21(27)16-11-15(28-5-2)7-8-17(16)22/h6-11,23H,4-5,12H2,1-3H3 BNCPRKFNMWSBJU-UHFFFAOYSA-N 181676 US9669035, B-22a cGMP-dependent 3',5'-cyclic phosphodiesterase Human 44 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181676&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153307 373987220 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476614 CCNCc1ccc2nc(C)c3nnc(-c4cc(OCC)ccc4Cl)n3c2c1 InChI=1S/C21H22ClN5O/c1-4-23-12-14-6-9-18-19(10-14)27-20(13(3)24-18)25-26-21(27)16-11-15(28-5-2)7-8-17(16)22/h6-11,23H,4-5,12H2,1-3H3 BNCPRKFNMWSBJU-UHFFFAOYSA-N 181676 US9669035, B-22a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 910 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181676&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153307 373987220 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476615 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNC(C)C)cc3n12 InChI=1S/C23H28N6O/c1-5-6-9-30-19-11-18(13-24-14-19)23-28-27-22-16(4)26-20-8-7-17(12-25-15(2)3)10-21(20)29(22)23/h7-8,10-11,13-15,25H,5-6,9,12H2,1-4H3 BHMXFSJSWADVLS-UHFFFAOYSA-N 181678 US9669035, B-23 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 52 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181678&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153346 373987221 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476616 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNC(C)C)cc3n12 InChI=1S/C23H28N6O/c1-5-6-9-30-19-11-18(13-24-14-19)23-28-27-22-16(4)26-20-8-7-17(12-25-15(2)3)10-21(20)29(22)23/h7-8,10-11,13-15,25H,5-6,9,12H2,1-4H3 BHMXFSJSWADVLS-UHFFFAOYSA-N 181678 US9669035, B-23 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181678&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153346 373987221 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476617 CCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C21H24N6O/c1-4-8-28-17-10-16(12-23-13-17)21-26-25-20-14(3)24-18-7-6-15(11-22-5-2)9-19(18)27(20)21/h6-7,9-10,12-13,22H,4-5,8,11H2,1-3H3 YGNSXEDMBFIFRU-UHFFFAOYSA-N 181713 US9669035, B-24 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 190 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181713&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153319 373987222 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476618 CCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNCC)cc3n12 InChI=1S/C21H24N6O/c1-4-8-28-17-10-16(12-23-13-17)21-26-25-20-14(3)24-18-7-6-15(11-22-5-2)9-19(18)27(20)21/h6-7,9-10,12-13,22H,4-5,8,11H2,1-3H3 YGNSXEDMBFIFRU-UHFFFAOYSA-N 181713 US9669035, B-24 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181713&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153319 373987222 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476619 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNC)cc3n12 InChI=1S/C22H24ClN5O/c1-4-5-10-29-16-7-8-18(23)17(12-16)22-27-26-21-14(2)25-19-9-6-15(13-24-3)11-20(19)28(21)22/h6-9,11-12,24H,4-5,10,13H2,1-3H3 SRNXYBWTUXBFQS-UHFFFAOYSA-N 181755 US9669035, B-25 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 18 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181755&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152008 373987223 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476620 CCCCOc1ccc(Cl)c(c1)-c1nnc2c(C)nc3ccc(CNC)cc3n12 InChI=1S/C22H24ClN5O/c1-4-5-10-29-16-7-8-18(23)17(12-16)22-27-26-21-14(2)25-19-9-6-15(13-24-3)11-20(19)28(21)22/h6-9,11-12,24H,4-5,10,13H2,1-3H3 SRNXYBWTUXBFQS-UHFFFAOYSA-N 181755 US9669035, B-25 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 9100 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181755&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152008 373987223 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476621 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1cncc(OCC2CC2)c1 InChI=1S/C24H26N6O2/c1-16-23-27-28-24(19-11-20(13-25-12-19)32-15-17-2-3-17)30(23)22-10-18(4-5-21(22)26-16)14-29-6-8-31-9-7-29/h4-5,10-13,17H,2-3,6-9,14-15H2,1H3 OWGBOJPEZFHUMM-UHFFFAOYSA-N 181763 US9669035, B-26 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 22 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181763&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71153202 373987224 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476622 Cc1nc2ccc(CN3CCOCC3)cc2n2c(nnc12)-c1cncc(OCC2CC2)c1 InChI=1S/C24H26N6O2/c1-16-23-27-28-24(19-11-20(13-25-12-19)32-15-17-2-3-17)30(23)22-10-18(4-5-21(22)26-16)14-29-6-8-31-9-7-29/h4-5,10-13,17H,2-3,6-9,14-15H2,1H3 OWGBOJPEZFHUMM-UHFFFAOYSA-N 181763 US9669035, B-26 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 3600 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=181763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=181763&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71153202 373987224 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476623 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H26N6O/c1-5-6-9-29-18-11-17(12-23-13-18)22-26-25-21-15(2)24-19-8-7-16(14-27(3)4)10-20(19)28(21)22/h7-8,10-13H,5-6,9,14H2,1-4H3 BXZOMMFMRNCLGL-UHFFFAOYSA-N 182096 US9669035, B-27 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 74 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182096&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152000 373987225 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476624 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CN(C)C)cc3n12 InChI=1S/C22H26N6O/c1-5-6-9-29-18-11-17(12-23-13-18)22-26-25-21-15(2)24-19-8-7-16(14-27(3)4)10-20(19)28(21)22/h7-8,10-13H,5-6,9,14H2,1-4H3 BXZOMMFMRNCLGL-UHFFFAOYSA-N 182096 US9669035, B-27 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 9300 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182096&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152000 373987225 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476625 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNC)cc3n12 InChI=1S/C21H24N6O/c1-4-5-8-28-17-10-16(12-23-13-17)21-26-25-20-14(2)24-18-7-6-15(11-22-3)9-19(18)27(20)21/h6-7,9-10,12-13,22H,4-5,8,11H2,1-3H3 YGIXIOXEHQAKBB-UHFFFAOYSA-N 182226 US9669035, B-28 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 91 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182226&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71151975 373987226 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476626 CCCCOc1cncc(c1)-c1nnc2c(C)nc3ccc(CNC)cc3n12 InChI=1S/C21H24N6O/c1-4-5-8-28-17-10-16(12-23-13-17)21-26-25-20-14(2)24-18-7-6-15(11-22-3)9-19(18)27(20)21/h6-7,9-10,12-13,22H,4-5,8,11H2,1-3H3 YGIXIOXEHQAKBB-UHFFFAOYSA-N 182226 US9669035, B-28 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182226&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71151975 373987226 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476627 CCCCOc1cc(cnc1Cl)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H27ClN6O2/c1-3-4-9-33-21-13-18(14-26-22(21)25)24-29-28-23-16(2)27-19-6-5-17(12-20(19)31(23)24)15-30-7-10-32-11-8-30/h5-6,12-14H,3-4,7-11,15H2,1-2H3 PKPRTWSDEQLHCM-UHFFFAOYSA-N 182234 US9669035, B-29 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 120 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182234&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89315909 373987227 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476628 CCCCOc1cc(cnc1Cl)-c1nnc2c(C)nc3ccc(CN4CCOCC4)cc3n12 InChI=1S/C24H27ClN6O2/c1-3-4-9-33-21-13-18(14-26-22(21)25)24-29-28-23-16(2)27-19-6-5-17(12-20(19)31(23)24)15-30-7-10-32-11-8-30/h5-6,12-14H,3-4,7-11,15H2,1-2H3 PKPRTWSDEQLHCM-UHFFFAOYSA-N 182234 US9669035, B-29 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182234&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 89315909 373987227 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476629 CN(C)Cc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C22H24N6O/c1-14-21-25-26-22(17-9-18(11-23-10-17)29-13-15-4-5-15)28(21)20-8-16(12-27(2)3)6-7-19(20)24-14/h6-11,15H,4-5,12-13H2,1-3H3 KDLJETKCCNQONU-UHFFFAOYSA-N 182294 US9669035, B-30 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 130 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182294&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152083 373987228 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476630 CN(C)Cc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C22H24N6O/c1-14-21-25-26-22(17-9-18(11-23-10-17)29-13-15-4-5-15)28(21)20-8-16(12-27(2)3)6-7-19(20)24-14/h6-11,15H,4-5,12-13H2,1-3H3 KDLJETKCCNQONU-UHFFFAOYSA-N 182294 US9669035, B-30 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182294&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152083 373987228 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476631 CC(C)NCc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C23H26N6O/c1-14(2)25-10-17-6-7-20-21(8-17)29-22(15(3)26-20)27-28-23(29)18-9-19(12-24-11-18)30-13-16-4-5-16/h6-9,11-12,14,16,25H,4-5,10,13H2,1-3H3 WGKODRYPFIOLDM-UHFFFAOYSA-N 182857 US9669035, B-31 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 330 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182857&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71151996 373987229 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476632 CC(C)NCc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C23H26N6O/c1-14(2)25-10-17-6-7-20-21(8-17)29-22(15(3)26-20)27-28-23(29)18-9-19(12-24-11-18)30-13-16-4-5-16/h6-9,11-12,14,16,25H,4-5,10,13H2,1-3H3 WGKODRYPFIOLDM-UHFFFAOYSA-N 182857 US9669035, B-31 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus 1400 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182857&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71151996 373987229 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5 476633 CCNCc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C22H24N6O/c1-3-23-10-16-6-7-19-20(8-16)28-21(14(2)25-19)26-27-22(28)17-9-18(12-24-11-17)29-13-15-4-5-15/h6-9,11-12,15,23H,3-5,10,13H2,1-2H3 ZHOGIIGEXYVVFK-UHFFFAOYSA-N 182858 US9669035, B-32 cGMP-dependent 3',5'-cyclic phosphodiesterase Human 350 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795020 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=788&target=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182858&enzyme=cGMP-dependent+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71152085 373987230 1 MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE 1Z1L,3IBJ,3ITM,3ITU,3JAB,3JBQ,4C1I,4D08,4D09,4HTX,4HTZ,4JIB,5TZ3,5TZA,5TZC,5TZH,5TZW,5TZX,5TZZ,5U00,5U7D,5U7I,5U7J,5U7K,5U7L,6B96,6B97,6B98,6BLF,6C7D,6C7E,6C7F,6C7G,6C7I,6C7J,6CYB,6CYC,6CYD,6ZND,6ZQZ cGMP-dependent 3',5'-cyclic phosphodiesterase PDE2A_HUMAN O00408 B2R646 B3KRV5 E9PGI1 F6W5Z0 Q5J791 Q5J792 Q5J793 Q6ZMR1 476634 CCNCc1ccc2nc(C)c3nnc(-c4cncc(OCC5CC5)c4)n3c2c1 InChI=1S/C22H24N6O/c1-3-23-10-16-6-7-19-20(8-16)28-21(14(2)25-19)26-27-22(28)17-9-18(12-24-11-17)29-13-15-4-5-15/h6-9,11-12,15,23H,3-5,10,13H2,1-2H3 ZHOGIIGEXYVVFK-UHFFFAOYSA-N 182858 US9669035, B-32 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Rattus norvegicus >10000 7.8 25.00 C US Patent 10.7270/Q2Z60M6H aid1795021 US9669035 Megens, AA; Langlois, XJ; Andres-Gil, JI 6/6/2017 5/19/2018 Janssen Pharmaceutica NV http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=182858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1569&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=182858&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A&column=ki&startPg=0&Increment=50&submit=Search 71152085 373987230 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKAEDEPSPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNHLLLYELSSIIRIATKADGFALYFLGECNNSLCVFTPPGMKEGQPRLIPAGPITQGTTISAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMHFNLPARICRDIELFHFDIGPFENMWPGIFVYMIHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNNGLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLHNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKRDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLNQWEKVIRGEETAMWISGPATSKSTSEKPTRKVDD 2O8H,2OVV,2OVY,3HQW,3HQY,3HQZ,3HR1,3LXG,3QPN,3QPO,3QPP,3WYK,3WYL,3WYM,4AJD,4AJF,4AJG,4AJM,4DDL,4DFF,4MUW,4MVH,4P0N,4P1R,4PHW,4TPM,4TPP,5AXP,5AXQ,5B4K,5B4L,5EDE,5EDG,6K9U cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_RAT Q9QYJ6 Q6S9E6 Q6S9E7 Q6S9E8 Q6S9E9 Q9QYJ5